D018343Chemicals & DrugsD12.776.543.750.070.300.300.340.725D12.776.543.750.100.150.300.340.725D12.776.543.750.720.300.300.300.340.20014360.980004Receptors, Adrenergic, beta-2Faculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson24369795Ortega VE, Meyers DAThe Journal of allergy and clinical immunologyOrtega VE, Meyers DA. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol. 2014 Jan; 133(1):16-26.J Allergy Clin Immunol2014-01-01T00:00:002014Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.24621682Ortega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, Castro M, Chardon D, Erzurum SC, Israel E, Montealegre F, Wenzel SE, Peters SP, Meyers DA, Bleecker ERThe Lancet. Respiratory medicineOrtega VE, Hawkins GA, Moore WC, Hastie AT, Ampleford EJ, Busse WW, Castro M, Chardon D, Erzurum SC, Israel E, Montealegre F, Wenzel SE, Peters SP, Meyers DA, Bleecker ER. Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting ß agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med. 2014 Mar; 2(3):204-13.Lancet Respir Med2014-01-27T00:00:002014Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting ß agonist treatment in a multiethnic asthma population: a genetic study.BiochemistryWake Forest School of MedicineWendyMooreWendy C. Moore MD36.09040200000000-80.267005999999991041Moore, WendyProfessorGregoryHawkinsGregory A. Hawkins PhD36.09040200000000-80.26700599999999308Hawkins, GregoryProfessorAnnetteHastieAnnette T. Hastie PhD36.09040200000000-80.2670059999999931Hastie, AnnetteProfessorStephenPetersStephen Peters MD, PhD36.09040200000000-80.26700599999999927Peters, StephenProfessor30872116Cardet JC, Jiang X, Lu Q, Gerard N, McIntire K, Boushey HA, Castro M, Chinchilli VM, Codispoti CD, Dyer AM, Holguin F, Kraft M, Lazarus S, Lemanske RF, Lugogo N, Mauger D, Moore WC, Moy J, Ortega VE, Peters SP, Smith LJ, Solway J, Sorkness CA, Sumino K, Wechsler ME, Wenzel S, Israel EThe Journal of allergy and clinical immunologyCardet JC, Jiang X, Lu Q, Gerard N, McIntire K, Boushey HA, Castro M, Chinchilli VM, Codispoti CD, Dyer AM, Holguin F, Kraft M, Lazarus S, Lemanske RF, Lugogo N, Mauger D, Moore WC, Moy J, Ortega VE, Peters SP, Smith LJ, Solway J, Sorkness CA, Sumino K, Wechsler ME, Wenzel S, Israel E. Loss of bronchoprotection with ICS plus LABA treatment, ß-receptor dynamics, and the effect of alendronate. J Allergy Clin Immunol. 2019 08; 144(2):416-425.e7.J Allergy Clin Immunol2019-03-11T00:00:002019Loss of bronchoprotection with ICS plus LABA treatment, ß-receptor dynamics, and the effect of alendronate.43Section ChiefChadGrotegutChad A. Grotegut MD, MBA, MPH2608Grotegut, ChadProfessorInternal Medicine, Pulmonary, Critical Care, Allergy and Immunologic DiseasesObstetrics and Gynecology, Maternal Fetal30591079Kim J, Grotegut CA, Wisler JW, Li T, Mao L, Chen M, Chen W, Rosenberg PB, Rockman HA, Lefkowitz RJSkeletal muscleKim J, Grotegut CA, Wisler JW, Li T, Mao L, Chen M, Chen W, Rosenberg PB, Rockman HA, Lefkowitz RJ. ß-arrestin 1 regulates ß2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility. Skelet Muscle. 2018 12 27; 8(1):39.Skelet Muscle2018-12-27T00:00:002018ß-arrestin 1 regulates ß2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor22383665Bleecker ER, Meyers DA, Bailey WC, Sims AM, Bujac SR, Goldman M, Martin UJChestBleecker ER, Meyers DA, Bailey WC, Sims AM, Bujac SR, Goldman M, Martin UJ. ADRB2 polymorphisms and budesonide/formoterol responses in COPD. Chest. 2012 Aug; 142(2):320-328.Chest2012-08-01T00:00:002012ADRB2 polymorphisms and budesonide/formoterol responses in COPD.1.315950.028389114research area of0.7084840.064353539subject area for